Pharma Stock to Watch: Gilead Sciences, Inc. (NASDAQ: GILD)
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell over 2% in the pre-market session on April 30th, 2021 (Source: Google finance) after the company posted mixed…
Posts Tagged: NASDAQ: GILD
Why Gilead Sciences, Inc. (NASDAQ: GILD) Stock Is Declining
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell over 1.4% on 29th October, 2020 (As of 11:08 am GMT-4; Source: Google finance) after the company posted…
Why Gilead Sciences, Inc. (NASDAQ: GILD) stock is under spotlight
Gilead Sciences, Inc. (NASDAQ: GILD), maker of the closely-watched experimental coronavirus drug remdesivir, stock generated over 22.9% in this year to date (as of May…
Healthcare stock under pressure: Gilead Sciences, Inc. (NASDAQ: GILD)
Gilead Sciences, Inc. (NASDAQ: GILD) stock lost over 4.6% on 25th October, 2019 (as of 12:31 pm GMT-4; Source: Google finance) after the company posted…
Why Gilead Sciences, Inc. (NASDAQ: GILD) stock is getting hammered
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell over 2.7% on Feb 5th, 2019 (Source: Google finance). The company has delivered the quarterly net income of…
Why Gilead Sciences, Inc. (NASDAQ: GILD) stock is under pressure
Gilead Sciences, Inc. (NASDAQ: GILD) stock fell after the in the fourth quarter of FY 17 results. The company has reported the net loss of…
Why Gilead Sciences, Inc.(NASDAQ: GILD) stock is falling
Gilead Sciences, Inc.(NASDAQ: GILD) stock lost over 5.3% on October 27th, 2017 (as of 11:20AM EDT; Source: Google finance) hurt by the group’s weak product…
Why Gilead Sciences Inc (NASDAQ: GILD) is stock dropping
Missed consensus estimates Gilead Sciences Inc (NASDAQ: GILD) missed consensus estimates for revenues and EPS for Q1FY18. The company reported revenues of $6.51 billion and…